A pattern found after examining trial data can identify a research question without becoming a clinical prediction rule. The distinction is particularly important when a symptom measured during treatment is presented as if it predicted the outcome before treatment began.
Who was included in the reanalysis?
Zorick and colleagues’ 2011 paper reanalyzed a 12-week sertraline trial. Of 229 randomized participants, 129 completed at least eight weeks and entered this analysis: 61 assigned sertraline and 68 placebo. Sertraline began orally at 50 mg/day and increased to 100 mg/day on day eight. Participants also received psychosocial treatment.
The investigators compared baseline methamphetamine-positive urine proportions with weeks 8–12. A greater-than-15% increase classified 13 sertraline participants and five placebo participants as increased users. The 15% breakpoints came from the observed distribution, rather than an independently validated rule. Classification-tree analyses identified sustained in-treatment craving as characteristic of the sertraline subgroup with increased use. Only 18 people comprised the increased-use subgroup.
Three limits on interpreting the finding
First, a retained-participant analysis is not the same population as the original randomized sample. Requiring eight weeks of participation introduces selection after assignment. A report should preserve that condition before quoting the subgroup percentages.
Second, a data-derived threshold can be useful for exploration while remaining sensitive to the particular sample. Demonstrating prediction would require checking the rule in appropriate independent data, with attention to false positives, false negatives and calibration. A statistically significant group comparison does not perform that validation.
Third, craving measured during treatment and drug use during treatment share a timeline. Their association does not by itself establish that craving caused the increased use, or that sertraline produced the pattern through a particular biological mechanism. Temporal detail and a suitable causal design would be needed to distinguish those explanations.
What the urine outcome means
The classification was based on a change in the proportion of positive specimens. It was not a direct measurement of an increase in milligrams consumed. It also was not a test of driving impairment. Keeping the outcome in its original form prevents a percentage classification from acquiring a different biological meaning in an expert report.
The paper supplies a cautionary historical observation about a specific treatment experiment. It does not establish that the same response occurs with every serotonin-related medicine, nor does it replace assessment of an individual receiving an antidepressant for another indication. Treatment changes cannot be justified by relabeling this exploratory analysis as a validated personal forecast.
Source
Zorick T, Sugar CA, Hellemann G, Shoptaw S, London ED. Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine. Drug Alcohol Depend. 2011;118:500–503. doi:10.1016/j.drugalcdep.2011.04.015. Full text.